Figure 5.
Event-free survival (EFS) of patients undergoing nonmyeloablative haploidentical stem cell transplantation with post-transplantation cyclophosphamide according to number of nismatched HLA-antigens in any direction (GVH or HVG).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.